MYCN

MYCN

Target · Transcription factor

MYCN MYCN proto-oncogene, bHLH transcription factor · N-myc

MYCN (N-myc proto-oncogene protein, also known as bHLHe37, N-myc and NMYC) is a nuclear basic helix-loop-helix transcription factor of the MYC family. Amplification of the MYCN gene is associated with a variety of tumours, most notably neuroblastoma. Browse Assay Genie's current range of MYCN research reagents below, or read on for the biology behind the target.

Nuclear proteinbHLH transcription factorAmplified in neuroblastoma
464 aa
Protein length
~50 kDa
Molecular weight
2p24.3
Gene locus
bHLH protein
Protein family
Target information

What is MYCN (MYCN proto-oncogene, bHLH transcription factor)?

MYCN is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. The protein is located in the nucleus and must dimerise with another bHLH protein in order to bind DNA. In neuroblastoma cells, UniProt records that it positively regulates the transcription of MYCNOS, a gene that shares its locus.

The human MYCN gene encodes the N-myc proto-oncogene protein, which belongs to the basic helix-loop-helix group of proteins in HGNC classification. Multiple alternatively spliced transcript variants encoding different isoforms have been described for this gene, so researchers studying MYCN expression should consider which transcripts and isoforms are relevant to their work. Mouse and rat each carry an ortholog named Mycn.

The gene was originally named v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog, a name that reflects its relationship to the viral myc oncogene and its link to neuroblastoma. Other symbols and aliases include bHLHe37, N-myc, MYCNOT and NMYC. Amplification of the MYCN gene is associated with a variety of tumours, most notably neuroblastomas, which makes the protein a frequent subject in cancer biology. Researchers working with an MYCN antibody, MYCN ELISA kit or MYCN protein reagent are typically studying transcriptional control, tumour biology or MYC family function.

Neuroblastoma research

MYCN gene amplification is associated with tumours, most notably neuroblastomas, making the protein a central subject in studies of this cancer.

Transcriptional regulation

As a bHLH transcription factor that must dimerise with another bHLH protein to bind DNA, MYCN is studied in gene control.

MYC family comparisons

MYCN is a member of the MYC family, so it is examined alongside related family members to understand shared and distinct functions.

Oncogene amplification studies

Amplification of MYCN is linked to a variety of tumours, supporting work on how copy-number changes shape cancer biology.

Background

MYCN frequently asked questions

What does MYCN do?

MYCN is a nuclear basic helix-loop-helix transcription factor of the MYC family. It must dimerise with another bHLH protein to bind DNA. In neuroblastoma cells, it positively regulates transcription of MYCNOS, according to UniProt.

What other names and isoforms does MYCN have?

MYCN is also called N-myc, NMYC, bHLHe37 and MYCNOT, and was formerly named v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog. NCBI Gene reports multiple alternatively spliced transcript variants that encode different isoforms.

How is MYCN linked to disease, and is it conserved?

Amplification of the MYCN gene is associated with a variety of tumours, most notably neuroblastomas. Mouse and rat both have an ortholog called Mycn; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other MYC family members, bHLH transcription factors and neuroblastoma-related targets with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P04198; product specifications from Assay Genie datasheets.

MYCN Product listing